649 related articles for article (PubMed ID: 17008034)
1. Encapsulation of hydrophobic drugs in polymeric micelles through co-solvent evaporation: the effect of solvent composition on micellar properties and drug loading.
Aliabadi HM; Elhasi S; Mahmud A; Gulamhusein R; Mahdipoor P; Lavasanifar A
Int J Pharm; 2007 Feb; 329(1-2):158-65. PubMed ID: 17008034
[TBL] [Abstract][Full Text] [Related]
2. A novel use of an in vitro method to predict the in vivo stability of block copolymer based nano-containers.
Aliabadi HM; Brocks DR; Mahdipoor P; Lavasanifar A
J Control Release; 2007 Sep; 122(1):63-70. PubMed ID: 17644207
[TBL] [Abstract][Full Text] [Related]
3. Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A.
Aliabadi HM; Mahmud A; Sharifabadi AD; Lavasanifar A
J Control Release; 2005 May; 104(2):301-11. PubMed ID: 15907581
[TBL] [Abstract][Full Text] [Related]
4. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsilon-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B.
Falamarzian A; Lavasanifar A
Colloids Surf B Biointerfaces; 2010 Nov; 81(1):313-20. PubMed ID: 20674292
[TBL] [Abstract][Full Text] [Related]
5. The effect of block copolymer structure on the internalization of polymeric micelles by human breast cancer cells.
Mahmud A; Lavasanifar A
Colloids Surf B Biointerfaces; 2005 Oct; 45(2):82-9. PubMed ID: 16144761
[TBL] [Abstract][Full Text] [Related]
6. Self-associating poly(ethylene oxide)-b-poly(alpha-cholesteryl carboxylate-epsilon-caprolactone) block copolymer for the solubilization of STAT-3 inhibitor cucurbitacin I.
Mahmud A; Patel S; Molavi O; Choi P; Samuel J; Lavasanifar A
Biomacromolecules; 2009 Mar; 10(3):471-8. PubMed ID: 19175305
[TBL] [Abstract][Full Text] [Related]
7. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
[TBL] [Abstract][Full Text] [Related]
8. Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells.
Xiong XB; Mahmud A; Uludağ H; Lavasanifar A
Biomacromolecules; 2007 Mar; 8(3):874-84. PubMed ID: 17315946
[TBL] [Abstract][Full Text] [Related]
9. Monolayer-protected gold nanoparticles by the self-assembly of micellar poly(ethylene oxide)-b-poly(epsilon-caprolactone) block copolymer.
Azzam T; Eisenberg A
Langmuir; 2007 Feb; 23(4):2126-32. PubMed ID: 17279704
[TBL] [Abstract][Full Text] [Related]
10. PEG-b-PPS diblock copolymer aggregates for hydrophobic drug solubilization and release: cyclosporin A as an example.
Velluto D; Demurtas D; Hubbell JA
Mol Pharm; 2008; 5(4):632-42. PubMed ID: 18547055
[TBL] [Abstract][Full Text] [Related]
11. Encapsulation of amphotericin B in poly(ethylene glycol)-block-poly(epsilon-caprolactone-co-trimethylenecarbonate) polymeric micelles.
Vandermeulen G; Rouxhet L; Arien A; Brewster ME; Préat V
Int J Pharm; 2006 Feb; 309(1-2):234-40. PubMed ID: 16406402
[TBL] [Abstract][Full Text] [Related]
12. Novel self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery.
Shahin M; Lavasanifar A
Int J Pharm; 2010 Apr; 389(1-2):213-22. PubMed ID: 20080163
[TBL] [Abstract][Full Text] [Related]
13. Core-cross-linked polymeric micelles as paclitaxel carriers.
Shuai X; Merdan T; Schaper AK; Xi F; Kissel T
Bioconjug Chem; 2004; 15(3):441-8. PubMed ID: 15149170
[TBL] [Abstract][Full Text] [Related]
14. Chemical modification of hydrophobic block in poly(ethylene oxide) poly(caprolactone) based nanocarriers: effect on the solubilization and hemolytic activity of amphotericin B.
Falamarzian A; Lavasanifar A
Macromol Biosci; 2010 Jun; 10(6):648-56. PubMed ID: 20352627
[TBL] [Abstract][Full Text] [Related]
15. Self-assembled micelles of biodegradable triblock copolymers based on poly(ethyl ethylene phosphate) and poly(-caprolactone) as drug carriers.
Wang YC; Tang LY; Sun TM; Li CH; Xiong MH; Wang J
Biomacromolecules; 2008 Jan; 9(1):388-95. PubMed ID: 18081252
[TBL] [Abstract][Full Text] [Related]
16. Self-assembled honokiol-loaded micelles based on poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer.
Wei X; Gong C; Shi S; Fu S; Men K; Zeng S; Zheng X; Gou M; Chen L; Qiu L; Qian Z
Int J Pharm; 2009 Mar; 369(1-2):170-5. PubMed ID: 19028556
[TBL] [Abstract][Full Text] [Related]
17. Molecular implications in the nanoencapsulation of the anti-tuberculosis drug rifampicin within flower-like polymeric micelles.
Moretton MA; Glisoni RJ; Chiappetta DA; Sosnik A
Colloids Surf B Biointerfaces; 2010 Sep; 79(2):467-79. PubMed ID: 20627665
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of self-assembled nanoparticles formed by poly(ethylene oxide)-block-poly(epsilon-caprolactone) copolymers with long poly(epsilon-caprolactone) blocks in aqueous solutions.
Sachl R; Uchman M; Matĕjícek P; Procházka K; Stĕpánek M; Spírková M
Langmuir; 2007 Mar; 23(6):3395-400. PubMed ID: 17269809
[TBL] [Abstract][Full Text] [Related]
19. Roles of nonpolar and polar intermolecular interactions in the improvement of the drug loading capacity of PEO-b-PCL with increasing PCL content for two hydrophobic Cucurbitacin drugs.
Patel SK; Lavasanifar A; Choi P
Biomacromolecules; 2009 Sep; 10(9):2584-91. PubMed ID: 19655789
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable and biocompatible multi-arm star amphiphilic block copolymer as a carrier for hydrophobic drug delivery.
Aryal S; Prabaharan M; Pilla S; Gong S
Int J Biol Macromol; 2009 May; 44(4):346-52. PubMed ID: 19428465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]